FDA-DTC genetics meeting

less than 1 minute read

The U.S. Food and Drug Administration has been holding a meeting about Direct-to-Consumer genetic testing. Daniel MacArthur has been following the proceedings remotely and his summary of the first day hits the highlights of the Twitter feed over the course of the day. An excerpt:

My overall impression from reports on the panel discussion, though, is somewhat ominous: both Dan and Alicia noted an apparent consensus among the panel members that genetic results should be returned via a physician

One of the heavy-hitters in favor of greater regulation was Nancy Wexler, famous for her work on the genetics of Huntington’s Disease.